Discover how p53 status determines whether estrogen receptor beta acts as a tumor suppressor or promoter in breast cancer, with implications for triple-negative breast cancer treatment.
Discover how TP53 status determines medulloblastoma response to valproic acid treatment in this comprehensive scientific overview.
Breakthrough research on Eprenetapopt with Azacitidine as maintenance therapy for TP53-mutated AML or MDS after stem cell transplantation